AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206,046,591 | -16.2% | 16,944,621 | -13.4% | 9.80% | +3.9% |
| Q2 2023 | $245,761,030 | +20.8% | 19,566,961 | +6.7% | 9.43% | +6.8% |
| Q1 2023 | $203,466,688 | -17.7% | 18,346,861 | -9.4% | 8.83% | -12.7% |
| Q4 2022 | $247,249,924 | +9.0% | 20,249,789 | -6.8% | 10.11% | +15.0% |
| Q3 2022 | $226,748,000 | -4.7% | 21,719,191 | -2.0% | 8.80% | -3.2% |
| Q2 2022 | $237,986,000 | +12.5% | 22,158,891 | -0.8% | 9.09% | +37.7% |
| Q1 2022 | $211,459,000 | -19.4% | 22,329,386 | -1.7% | 6.60% | +10.7% |
| Q4 2021 | $262,371,000 | +32.1% | 22,716,086 | +9.2% | 5.96% | +72.2% |
| Q3 2021 | $198,633,000 | -0.9% | 20,799,303 | 0.0% | 3.46% | +16.8% |
| Q2 2021 | $200,505,000 | -3.9% | 20,799,303 | -1.5% | 2.97% | +1.0% |
| Q1 2021 | $208,607,000 | -56.2% | 21,114,114 | +2.4% | 2.94% | -49.0% |
| Q4 2020 | $476,127,000 | +46.1% | 20,620,490 | -10.6% | 5.76% | -3.6% |
| Q3 2020 | $325,830,000 | -13.4% | 23,075,807 | -7.5% | 5.98% | -13.9% |
| Q2 2020 | $376,166,000 | +61.7% | 24,944,695 | -0.9% | 6.94% | +6.5% |
| Q1 2020 | $232,677,000 | -5.2% | 25,181,500 | -0.1% | 6.52% | +11.1% |
| Q4 2019 | $245,545,000 | +34.3% | 25,209,964 | +10.6% | 5.87% | -4.0% |
| Q3 2019 | $182,777,000 | -35.7% | 22,790,134 | -0.0% | 6.12% | -24.0% |
| Q2 2019 | $284,452,000 | +6.6% | 22,792,634 | +16.2% | 8.05% | +3.1% |
| Q1 2019 | $266,778,000 | +234.6% | 19,616,062 | +135.7% | 7.81% | +143.4% |
| Q4 2018 | $79,736,000 | -21.5% | 8,323,217 | -0.9% | 3.21% | +2.6% |
| Q3 2018 | $101,588,000 | -38.1% | 8,402,617 | -20.1% | 3.12% | -44.0% |
| Q2 2018 | $164,193,000 | +1.7% | 10,511,732 | -2.1% | 5.58% | -10.6% |
| Q1 2018 | $161,509,000 | +11.9% | 10,738,658 | +7.1% | 6.24% | -0.6% |
| Q4 2017 | $144,271,000 | -13.1% | 10,025,770 | -9.0% | 6.27% | -23.4% |
| Q3 2017 | $166,069,000 | +36.9% | 11,012,561 | -8.6% | 8.19% | +11.0% |
| Q2 2017 | $121,282,000 | +49.5% | 12,043,932 | +5.9% | 7.38% | +40.3% |
| Q1 2017 | $81,110,000 | +32.3% | 11,375,852 | -7.7% | 5.26% | -0.4% |
| Q4 2016 | $61,286,000 | -35.1% | 12,331,130 | -3.3% | 5.28% | -29.6% |
| Q3 2016 | $94,361,000 | +55.6% | 12,751,536 | +14.8% | 7.50% | +29.6% |
| Q2 2016 | $60,641,000 | -33.0% | 11,106,446 | +3.6% | 5.79% | -37.5% |
| Q1 2016 | $90,571,000 | -9.2% | 10,718,420 | +4.3% | 9.27% | +24.2% |
| Q4 2015 | $99,722,000 | -14.5% | 10,280,620 | +23.4% | 7.46% | -15.5% |
| Q3 2015 | $116,578,000 | +30.8% | 8,332,930 | +32.3% | 8.83% | +20.9% |
| Q2 2015 | $89,110,000 | +40.4% | 6,297,523 | +8.0% | 7.30% | +28.2% |
| Q1 2015 | $63,455,000 | +10.9% | 5,832,228 | -15.2% | 5.70% | -8.5% |
| Q4 2014 | $57,202,000 | +68.5% | 6,875,274 | +20.5% | 6.23% | +58.8% |
| Q3 2014 | $33,956,000 | +32.9% | 5,706,906 | -25.4% | 3.92% | +26.6% |
| Q2 2014 | $25,552,000 | +45.3% | 7,650,268 | -10.0% | 3.10% | +47.6% |
| Q1 2014 | $17,588,000 | -13.5% | 8,496,538 | -1.8% | 2.10% | -16.3% |
| Q4 2013 | $20,323,000 | +254.1% | 8,648,087 | +249.6% | 2.51% | +190.3% |
| Q3 2013 | $5,739,000 | +3.8% | 2,473,787 | +4.2% | 0.86% | -11.4% |
| Q2 2013 | $5,531,000 | -12.4% | 2,373,687 | +19.2% | 0.98% | -15.9% |
| Q1 2013 | $6,313,000 | – | 1,991,490 | – | 1.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |